Verition Fund Management
KNSA icon

Verition Fund Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Verition Fund Management’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$480K Buy
+7,500
New +$389K ﹤0.01% 1651
2025
Q3 		– Sell
-21,368
Closed -$591K – 3893
2025
Q2 		$591K Sell
21,368
-6,625
-24% -$169K ﹤0.01% 2828
2025
Q1 		$622K Sell
27,993
-26,735
-49% -$550K ﹤0.01% 2435
2024
Q4 		$1.08M Buy
54,728
+27,944
+104% +$638K ﹤0.01% 1992
2024
Q3 		$669K Buy
+26,784
New +$652K ﹤0.01% 2140
2020
Q2 		– Sell
-19,700
Closed -$305K – 1115
2020
Q1 		$305K Buy
+19,700
New +$308K 0.01% 424

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Verition Fund Management's KNSA Position: Q2 2026 in Review

Verition Fund Management opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q2 2026: 7,500 shares worth $480K. The stake represents ﹤0.01% of the portfolio and ranks #1651 among its holdings. This is a return to the name: Verition Fund Management previously reported a position in KNSA as recently as Q2 2025.

Verition Fund Management first reported a position in KNSA in Q1 2020 and has held it in 6 quarters since. The position peaked at $1.08M in Q4 2024. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Verition Fund Management held 7,500 shares of Kiniksa Pharmaceuticals worth $480K as of Q2 2026.
  • Kiniksa Pharmaceuticals was a new Verition Fund Management position in Q2 2026.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Verition Fund Management's portfolio in Q2 2026, its #1651 holding.
  • Verition Fund Management first reported a position in Kiniksa Pharmaceuticals in Q1 2020 and has held it in 6 quarters since.
  • Verition Fund Management's Kiniksa Pharmaceuticals position peaked at $1.08M in Q4 2024.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.